
Voage-MS 10mg/500mg Tablet ER
Marketer
Alembic Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Voage-MS 10mg/500mg Tablet ER
Diabetica Duo 10mg/500mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This dual-action therapy helps regulate elevated blood glucose, mitigating the risk of severe diabetic complications, including cardiovascular disease. Diabetica Duo should be ingested with meals, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; discontinuation requires medical consultation to avoid potential blood sugar spikes and associated risks like kidney impairment and vision loss. This medication is one element of a comprehensive treatment plan that necessitates a doctor-recommended diet, exercise regimen, and weight management strategy. Common side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration is crucial to minimize dehydration. Genital fungal infections are a possibility; diligent hygiene can help reduce this risk. Prior to commencing treatment, discuss any existing kidney or liver conditions, urinary tract infections, diuretic use, or pregnancy/breastfeeding status with your doctor. Limit alcohol consumption as it may intensify side effects. Regular blood glucose monitoring is essential during treatment.
Uses of Voage-MS 10mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Voage-MS 10mg/500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voage-MS 10mg/500mg Extended-Release tablets with food.
Common Side effects of Voage-MS 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Voage-MS 10mg/500mg Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the Voage-MS 10mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Voage-MS 10mg/500mg Tablet ER works:
Voage-MS 10mg/500mg Extended-Release tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin promotes glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action improves glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Voage-MS 10mg/500mg extended-release tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Voage-MS 10mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voage-MS 10mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Voage-MS 10mg/500mg Extended-Release tablets. Dosage modification of Voage-MS 10mg/500mg Extended-Release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should use Voage-MS 10mg/500mg extended-release tablets cautiously. Dosage modification of Voage-MS 10mg/500mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Voage-MS 10mg/500mg Tablet ER :
Should you forget a Voage-MS 10mg/500mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voage-MS 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | Medication for diabetes |
